Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Is There Still a Role for Axillary Dissection in Breast Cancer Surgery?

Is There Still a Role for Axillary Dissection in Breast Cancer Surgery? The operative management of breast cancer has followed a natural progression toward less invasive techniques over the past century as chemotherapy, hormonal therapy, and radiation therapy have become more effective and used more frequently. Sentinel lymph node (SLN) biopsy in clinically node-negative patients has replaced axillary lymph node dissection (ALND), resulting in improved staging and decreased morbidity. ALND has remained important for patients with clinically involved lymph nodes or positive SLN; however, new evidence from the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial has identified a subset of patients with breast cancer who do not benefit from axillary lymphadenectomy following a positive SLN biopsy. These results are practice changing and need to be analyzed within the context of patient selection and multidisciplinary treatment. Herein, we review the emerging data regarding the benefits and indications for axillary lymphadenectomy in the modern era of multidisciplinary breast cancer management. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Breast Cancer Reports Springer Journals

Is There Still a Role for Axillary Dissection in Breast Cancer Surgery?

Grotz, Travis; Boughey, Judy
Current Breast Cancer Reports , Volume 4 (2) – Mar 14, 2012
Download PDF
9 pages

Loading next page...
 
/lp/springer-journals/is-there-still-a-role-for-axillary-dissection-in-breast-cancer-surgery-YbW8ORYqiU
Publisher
Springer Journals
Copyright
Copyright © 2012 by Springer Science+Business Media, LLC
Subject
Medicine & Public Health; Internal Medicine; Surgical Oncology; Oncology
ISSN
1943-4588
eISSN
1943-4596
DOI
10.1007/s12609-012-0074-8
Publisher site
See Article on Publisher Site

Abstract

The operative management of breast cancer has followed a natural progression toward less invasive techniques over the past century as chemotherapy, hormonal therapy, and radiation therapy have become more effective and used more frequently. Sentinel lymph node (SLN) biopsy in clinically node-negative patients has replaced axillary lymph node dissection (ALND), resulting in improved staging and decreased morbidity. ALND has remained important for patients with clinically involved lymph nodes or positive SLN; however, new evidence from the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial has identified a subset of patients with breast cancer who do not benefit from axillary lymphadenectomy following a positive SLN biopsy. These results are practice changing and need to be analyzed within the context of patient selection and multidisciplinary treatment. Herein, we review the emerging data regarding the benefits and indications for axillary lymphadenectomy in the modern era of multidisciplinary breast cancer management.

Journal

Current Breast Cancer Reports – Springer Journals

Published: Mar 14, 2012

References

  • Recent major progress in long-term cancer patient survival disclosed by modeled period analysis
    Brenner, H; Gondos, A; Arndt, V
  • Morbidity of sentinel lymph node biopsy (SLN) alone versus SLN and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 patients
    Langer, I; Guller, U; Berclaz, G
  • Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial
    Giuliano, AE; McCall, L; Beitsch, P
  • Avoiding axillary treatment in sentinel lymph node micrometastases of breast cancer: a prospective analysis of axillary or distant recurrence
    Pernas, S; Gil, M; Benitez, A
  • Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study
    Langer, I; Guller, U; Viehl, CT
  • Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial
    Krag, DN; Anderson, SJ; Julian, TB
  • Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?
    Zakaria, S; Pantvaidya, G; Reynolds, CA
  • Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases
    Carter, CL; Allen, C; Henson, DE
  • Management and survival of female breast cancer: results of a national survey by the American College of Surgeons
    Nemoto, T; Vana, J; Bedwani, RN
  • The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer
    Truong, PT; Vinh-Hung, V; Cserni, G
  • A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy
    Zee, KJ; Manasseh, DM; Bevilacqua, JL
  • Clinicopathologic features of metastasis in nonsentinel lymph nodes of breast carcinoma patients
    Degnim, AC; Griffith, KA; Sabel, MS
  • Node-related factors and survival in node-positive breast carcinomas
    Sivridis, E; Giatromanolaki, A; Galazios, G; Koukourakis, MI
  • The number of axillary lymph nodes involved with metastatic breast cancer does not affect outcome as long as all disease is confined to the sentinel lymph nodes
    Jakub, JW; Bryant, K; Huebner, M
  • Improved axillary staging of breast cancer with sentinel lymphadenectomy
    Giuliano, AE; Dale, PS; Turner, RR
  • Patients with preoperatively ultrasonically uninvolved axillary lymph nodes: a distinct subgroup of early breast cancer patients
    Zgajnar, J; Hocevar, M; Podkrajsek, M
  • Dynamic contrast enhanced MRI of the axilla in women with breast cancer: comparison with pathology of excised nodes
    Murray, AD; Staff, RT; Redpath, TW
  • MR-axillography oriented surgical sampling for assessment of nodal status in the selection of patients with breast cancer for axillary lymph nodes dissection
    Suzuma, T; Sakurai, T; Yoshimura, G
  • The use of FDG-PET in assessing axillary lymph node status in breast cancer: a systematic review and meta-analysis of the literature
    Peare, R; Staff, RT; Heys, SD
  • Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer?
    Neal, CH; Daly, CP; Nees, AV; Helvie, MA
  • Fluorodeoxyglucose positron emission tomography with sentinel lymph node biopsy for evaluation of axillary involvement in breast cancer
    Gil-Rendo, A; Zornoza, G; Garcia-Velloso, MJ
  • Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial
    Ragaz, J; Olivotto, IA; Spinelli, JJ
  • Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials
    Taghian, AG; Jeong, JH; Mamounas, EP
  • Breast cancer prognosis determined by gene expression profiling: a quantitative reverse transcriptase polymerase chain reaction study
    Espinosa, E; Vara, JA; Redondo, A
  • Trial assessing individualized options for treatment for breast cancer: the TAILORx trial
    Zujewski, JA; Kamin, L
  • Gene signature evaluation as a prognostic tool: challenges in the design of the MINDACT trial
    Bogaerts, J; Cardoso, F; Buyse, M
  • How important is the axillary nodal status for adjuvant treatment decisions at a breast cancer multidisciplinary tumor board? A survival analysis
    Reimer, T; Fietkau, R; Markmann, S
  • Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial
    Fisher, B; Montague, E; Redmond, C
  • Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation
    Fisher, B; Jeong, JH; Anderson, S
  • The significance of local control in the primary treatment of breast cancer. Lucy Wortham James clinical research award
    Hayward, J; Caleffi, M
  • Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review
    Pepels, MJ; Vestjens, JH; Boer, M
  • Impact of omission of completion axillary lymph node dissection (cALND) or axillary radiotherapy (ax RT) in breast cancer patients with micrometastases (pN1mi) or isolated tumor cells (pN0(i+)) in the sentinel lymph node (SN): results from the MIRROR study
    Tjan-Heijnen, V; Pepels, M; Boer, M
  • Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials
    Clarke, M; Collins, R; Darby, S
  • The impact of prophylactic axillary node dissection on breast cancer survival–a Bayesian meta-analysis
    Orr, RK
  • Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial
    Giuliano, AE; Hunt, KK; Ballman, KV
  • Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group
    Cote, RJ; Peterson, HF; Chaiwun, B
  • Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study
    Reed, J; Rosman, M; Verbanac, KM
  • Association of occult metastases in sentinel lymph nodes and bone marrow with survival among women with early-stage invasive breast cancer
    Giuliano, AE; Hawes, D; Ballman, KV
  • Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort study
    Fisher, CS; Cole, DJ; Mitas, M